ADARx Pharmaceuticals

ADARx Pharmaceuticals is a clinical-stage biopharmaceutical company developing RNA-targeted therapeutics. Its platform uses siRNA and ADAR-mediated RNA editing technologies. The company aims to treat a broad range of diseases, including cardiovascular, metabolic, neurological and other conditions.